Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tooth hard tissue mineral matrix is primarily composed of carbonated hydroxyapatite, a crystalline calcium phosphate that provides the structural integrity and hardness required for mastication (StatPearls, 2023). This matrix constitutes the bulk of enamel, dentin, and cementum, serving as a protective barrier for the underlying dental pulp and a reservoir for essential ions like calcium and phosphate (NIH, 2023). In the context of dental health, this matrix is a dynamic environment that undergoes constant cycles of demineralization and remineralization influenced by oral pH and microbial activity (Journal of Dental Research, 2018). Therapeutic interventions often target this matrix to prevent or reverse dental caries and erosion. For instance, fluoride ions interact with the matrix to form fluorapatite, which is significantly more resistant to acid dissolution than the original hydroxyapatite (PubChem, 2024). Additionally, various remineralizing agents, such as casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), aim to restore the mineral density of the matrix to treat conditions like dentin hypersensitivity and early-stage carious lesions (Journal of Dentistry, 2019). The interaction between therapeutic agents and the mineral matrix is crucial for maintaining the longevity of the natural dentition.
The primary mechanism involves the promotion of remineralization by providing calcium and phosphate ions to the matrix surface and the substitution of hydroxyl groups in the hydroxyapatite lattice with fluoride to form acid-resistant fluorapatite (NIH, 2023; PubChem, 2024).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tooth hard tissue mineral matrix (HAp) (HAp).